Oppenheimer & Co. Inc. boosted its holdings in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 77.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 181,528 shares of the construction company's stock after buying an additional 78,993 shares during the quarter. Oppenheimer & Co. Inc. owned approximately 0.22% of Aspen Aerogels worth $2,157,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the stock. Franklin Resources Inc. increased its stake in Aspen Aerogels by 5.3% during the 3rd quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company's stock valued at $815,000 after purchasing an additional 1,483 shares in the last quarter. Greenwood Capital Associates LLC lifted its holdings in shares of Aspen Aerogels by 5.0% in the fourth quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company's stock worth $439,000 after buying an additional 1,749 shares in the last quarter. Rhumbline Advisers raised its holdings in shares of Aspen Aerogels by 2.8% in the 4th quarter. Rhumbline Advisers now owns 93,044 shares of the construction company's stock valued at $1,105,000 after acquiring an additional 2,554 shares in the last quarter. Ballentine Partners LLC raised its position in Aspen Aerogels by 19.2% during the fourth quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company's stock valued at $189,000 after purchasing an additional 2,565 shares in the last quarter. Finally, Bridgewater Advisors Inc. boosted its stake in shares of Aspen Aerogels by 6.5% in the 4th quarter. Bridgewater Advisors Inc. now owns 82,352 shares of the construction company's stock valued at $1,027,000 after purchasing an additional 4,995 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.
Aspen Aerogels Price Performance
ASPN stock traded down $0.10 on Thursday, reaching $7.74. 510,134 shares of the company's stock were exchanged, compared to its average volume of 2,101,826. The stock has a fifty day moving average of $10.88 and a 200-day moving average of $17.18. Aspen Aerogels, Inc. has a twelve month low of $6.70 and a twelve month high of $33.15. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The firm has a market cap of $635.04 million, a PE ratio of 48.33 and a beta of 2.14.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. As a group, equities analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of analysts recently commented on ASPN shares. StockNews.com raised Aspen Aerogels to a "sell" rating in a research note on Wednesday, February 19th. Canaccord Genuity Group reduced their price objective on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research report on Friday, February 14th. Seaport Res Ptn cut Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th. Roth Mkm lowered their target price on shares of Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. Finally, Craig Hallum cut their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a report on Friday, February 14th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, Aspen Aerogels has a consensus rating of "Moderate Buy" and a consensus target price of $22.44.
Get Our Latest Report on Aspen Aerogels
About Aspen Aerogels
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Recommended Stories

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.